The estimated Net Worth of Surbhi Sarna is at least 1.12 百万$ dollars as of 2 January 2024. Ms. Sarna owns over 85 units of Penumbra Inc stock worth over 464,301$ and over the last 5 years she sold PEN stock worth over 427,311$. In addition, she makes 229,895$ as Independent Director at Penumbra Inc.
Surbhi has made over 12 trades of the Penumbra Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 85 units of PEN stock worth 21,053$ on 2 January 2024.
The largest trade she's ever made was selling 907 units of Penumbra Inc stock on 1 November 2021 worth over 252,200$. On average, Surbhi trades about 89 units every 76 days since 2019. As of 2 January 2024 she still owns at least 2,295 units of Penumbra Inc stock.
You can see the complete history of Ms. Sarna stock trades at the bottom of the page.
Surbhi Sarna serves as Independent Director of the Company. Ms. Sarna is the CEO and founder of nVision Medical Corp (nVision), a healthcare company developing pioneering technology to enable early detection of ovarian cancer. Ms. Sarna founded nVision in 2011, with the intention of fulfilling an unmet clinical need. She has led the company from its inception and through its earliest days of product development, funding and initial clinical trials. In April 2018, nVision was acquired by Boston Scientific. Ms. Sarna now leads the efforts to commercialize the technology developed by nVision at Boston Scientific. Prior to her founding of nVision, Ms. Sarna held a variety of roles in healthcare, including roles at BioCardia and Abbott Vascular. Ms. Sarna received a B.A. from the University of California, Berkeley. The Board has nominated Ms. Sarna based on her valuable experience as Chief Executive Officer of a pioneering medical device company
As the Independent Director of Penumbra Inc, the total compensation of Surbhi Sarna at Penumbra Inc is 229,895$. There are 10 executives at Penumbra Inc getting paid more, with Johanna Roberts having the highest compensation of 2,556,370$.
Surbhi Sarna is 34, she's been the Independent Director of Penumbra Inc since 2019. There are 17 older and no younger executives at Penumbra Inc. The oldest executive at Penumbra Inc is Don Kassing, 78, who is the Presiding Independent Director.
Surbhi's mailing address filed with the SEC is ONE PENUMBRA PLACE, , ALAMEDA, CA, 94502.
Over the last 9 years, insiders at Penumbra Inc have traded over 197,637,326$ worth of Penumbra Inc stock and bought 700 units worth 109,480$ . The most active insiders traders include Adam Elsesser、Arani Bose、James Robert Pray. On average, Penumbra Inc executives and independent directors trade stock every 9 days with the average trade being worth of 2,030,383$. The most recent stock trade was executed by Harpreet Grewal on 4 September 2024, trading 782 units of PEN stock currently worth 159,614$.
penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.
Penumbra Inc executives and other stock owners filed with the SEC include: